ADCP Effect Evaluation Experiment

Antibody-dependent cellular phagocytosis (ADCP) is a process in which immune cells engulf target cells in the presence of antibodies. This process is initiated when the Fab end of the antibody binds to a ligand on the target cell's surface, and the Fc end of the antibody binds to FcγR on the phagocyte's surface. This interaction triggers a series of second messenger responses, resulting in the engulfment of the target cell by the phagocyte. The FcγR-mediated engulfment process not only helps fight infections but also plays a crucial role in cancer treatment.  

 

图片3.png



Case:Rituximab- induced ADCP effect detection.


图片4.png

Fig. Flow detection results of macrophages induced by monocytes derived from PBMC in vitro.


Using two different fluorescent dyes to label target cells and macrophages. After the macrophages ingest the target cells, they emit a double-positive signal (located in Stream graph Q2 quadrant).



图片5.png图片6.png

Fig. Rituximab Mediated phagocytosis (ADCP)


GPT Advantages


  • Extensive library of target cells (300+ cancer cell lines and humanized cell lines) and qualified BSL-2 level laboratories.

  • Providing free comparator antibody therapy for common viral infections.

  • Evaluating the effect of signal activation in a simulated genetic cell system (Jurkat-CD32a-NFAT-luc) for early screening of antibody drugs.

  • Analysis of M1/M2-type giant cell-derived ADCP effect.

  • Establishing sufficient QC detection standards for the differentiation and maturation of macrophages.

  • Extensive project experience.

  • Meeting the regulatory requirements for new drug application submissions.

  • Strict laboratory data storage standards ensure experiment traceability.


TALK WITH OUR EXPERTS

GemPharmatech is committed to protecting and respecting your privacy, and we'll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please click below to say how you would like us to contact you:

In order to provide you with the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please click the checkbox below.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.